Augmenting the Immune Response against a Stabilized HIV-1 Clade C Envelope Trimer by Silica Nanoparticle Delivery

The delivery of HIV-1 envelope (Env) trimer-based immunogens on the surface of nanoparticles holds promise to promote immunogenicity with the aim of inducing a potent, durable and broad neutralizing antibody (bnAb) response. Towards that goal, we examined the covalent conjugation of Env to 100 nm an...

Full description

Bibliographic Details
Main Authors: David Peterhoff, Stefanie Thalhauser, Jan M. Sobczak, Mona O. Mohsen, Christoph Voigt, Nicole Seifert, Patrick Neckermann, Alexandra Hauser, Song Ding, Quentin Sattentau, Martin F. Bachmann, Miriam Breunig, Ralf Wagner
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/9/6/642
_version_ 1797530505749463040
author David Peterhoff
Stefanie Thalhauser
Jan M. Sobczak
Mona O. Mohsen
Christoph Voigt
Nicole Seifert
Patrick Neckermann
Alexandra Hauser
Song Ding
Quentin Sattentau
Martin F. Bachmann
Miriam Breunig
Ralf Wagner
author_facet David Peterhoff
Stefanie Thalhauser
Jan M. Sobczak
Mona O. Mohsen
Christoph Voigt
Nicole Seifert
Patrick Neckermann
Alexandra Hauser
Song Ding
Quentin Sattentau
Martin F. Bachmann
Miriam Breunig
Ralf Wagner
author_sort David Peterhoff
collection DOAJ
description The delivery of HIV-1 envelope (Env) trimer-based immunogens on the surface of nanoparticles holds promise to promote immunogenicity with the aim of inducing a potent, durable and broad neutralizing antibody (bnAb) response. Towards that goal, we examined the covalent conjugation of Env to 100 nm and 200 nm silica nanoparticles (SiNPs) to optimize conjugation density and attachment stability. Env was redesigned to enable site-specific cysteine-mediated covalent conjugation while maintaining its structural integrity and antigenicity. Env was anchored to different sized SiNPs with a calculated spacing of 15 nm between adjacent trimers. Both particle sizes exhibited high in vitro stability over a seven-day period. After attachment, 100 nm particles showed better colloidal stability compared to 200 nm particles. Importantly, the antigenic profile of Env was not impaired by surface attachment, indicating that the quaternary structure was maintained. In vitro Env uptake by dendritic cells was significantly enhanced when Env was delivered on the surface of nanoparticles compared to soluble Env. Furthermore, multivalent Env displayed efficiently activated B cells even at Env concentrations in the low nanomolar range. In mice, antibody responses to nanoparticle-coupled Env were stronger compared to the free protein and had equivalent effects at lower doses and without adjuvant.
first_indexed 2024-03-10T10:29:56Z
format Article
id doaj.art-10e3fcc31e9c437b81c70b242bf689c0
institution Directory Open Access Journal
issn 2076-393X
language English
last_indexed 2024-03-10T10:29:56Z
publishDate 2021-06-01
publisher MDPI AG
record_format Article
series Vaccines
spelling doaj.art-10e3fcc31e9c437b81c70b242bf689c02023-11-21T23:42:32ZengMDPI AGVaccines2076-393X2021-06-019664210.3390/vaccines9060642Augmenting the Immune Response against a Stabilized HIV-1 Clade C Envelope Trimer by Silica Nanoparticle DeliveryDavid Peterhoff0Stefanie Thalhauser1Jan M. Sobczak2Mona O. Mohsen3Christoph Voigt4Nicole Seifert5Patrick Neckermann6Alexandra Hauser7Song Ding8Quentin Sattentau9Martin F. Bachmann10Miriam Breunig11Ralf Wagner12Institute of Medical Microbiology and Hygiene, Molecular Microbiology (Virology), University of Regensburg, 93053 Regensburg, GermanyInstitute of Pharmaceutical Technology, University of Regensburg, 93053 Regensburg, GermanyDepartment for BioMedical Research, University of Bern, 3010 Bern, SwitzerlandDepartment for BioMedical Research, University of Bern, 3010 Bern, SwitzerlandInstitute of Medical Microbiology and Hygiene, Molecular Microbiology (Virology), University of Regensburg, 93053 Regensburg, GermanyInstitute of Medical Microbiology and Hygiene, Molecular Microbiology (Virology), University of Regensburg, 93053 Regensburg, GermanyInstitute of Medical Microbiology and Hygiene, Molecular Microbiology (Virology), University of Regensburg, 93053 Regensburg, GermanyInstitute of Medical Microbiology and Hygiene, Molecular Microbiology (Virology), University of Regensburg, 93053 Regensburg, GermanyEuroVacc Foundation, 1002 Lausanne, SwitzerlandSir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, UKDepartment for BioMedical Research, University of Bern, 3010 Bern, SwitzerlandInstitute of Pharmaceutical Technology, University of Regensburg, 93053 Regensburg, GermanyInstitute of Medical Microbiology and Hygiene, Molecular Microbiology (Virology), University of Regensburg, 93053 Regensburg, GermanyThe delivery of HIV-1 envelope (Env) trimer-based immunogens on the surface of nanoparticles holds promise to promote immunogenicity with the aim of inducing a potent, durable and broad neutralizing antibody (bnAb) response. Towards that goal, we examined the covalent conjugation of Env to 100 nm and 200 nm silica nanoparticles (SiNPs) to optimize conjugation density and attachment stability. Env was redesigned to enable site-specific cysteine-mediated covalent conjugation while maintaining its structural integrity and antigenicity. Env was anchored to different sized SiNPs with a calculated spacing of 15 nm between adjacent trimers. Both particle sizes exhibited high in vitro stability over a seven-day period. After attachment, 100 nm particles showed better colloidal stability compared to 200 nm particles. Importantly, the antigenic profile of Env was not impaired by surface attachment, indicating that the quaternary structure was maintained. In vitro Env uptake by dendritic cells was significantly enhanced when Env was delivered on the surface of nanoparticles compared to soluble Env. Furthermore, multivalent Env displayed efficiently activated B cells even at Env concentrations in the low nanomolar range. In mice, antibody responses to nanoparticle-coupled Env were stronger compared to the free protein and had equivalent effects at lower doses and without adjuvant.https://www.mdpi.com/2076-393X/9/6/642HIV vaccinesilica nanoparticlesstabilized envelope trimerEnv
spellingShingle David Peterhoff
Stefanie Thalhauser
Jan M. Sobczak
Mona O. Mohsen
Christoph Voigt
Nicole Seifert
Patrick Neckermann
Alexandra Hauser
Song Ding
Quentin Sattentau
Martin F. Bachmann
Miriam Breunig
Ralf Wagner
Augmenting the Immune Response against a Stabilized HIV-1 Clade C Envelope Trimer by Silica Nanoparticle Delivery
Vaccines
HIV vaccine
silica nanoparticles
stabilized envelope trimer
Env
title Augmenting the Immune Response against a Stabilized HIV-1 Clade C Envelope Trimer by Silica Nanoparticle Delivery
title_full Augmenting the Immune Response against a Stabilized HIV-1 Clade C Envelope Trimer by Silica Nanoparticle Delivery
title_fullStr Augmenting the Immune Response against a Stabilized HIV-1 Clade C Envelope Trimer by Silica Nanoparticle Delivery
title_full_unstemmed Augmenting the Immune Response against a Stabilized HIV-1 Clade C Envelope Trimer by Silica Nanoparticle Delivery
title_short Augmenting the Immune Response against a Stabilized HIV-1 Clade C Envelope Trimer by Silica Nanoparticle Delivery
title_sort augmenting the immune response against a stabilized hiv 1 clade c envelope trimer by silica nanoparticle delivery
topic HIV vaccine
silica nanoparticles
stabilized envelope trimer
Env
url https://www.mdpi.com/2076-393X/9/6/642
work_keys_str_mv AT davidpeterhoff augmentingtheimmuneresponseagainstastabilizedhiv1cladecenvelopetrimerbysilicananoparticledelivery
AT stefaniethalhauser augmentingtheimmuneresponseagainstastabilizedhiv1cladecenvelopetrimerbysilicananoparticledelivery
AT janmsobczak augmentingtheimmuneresponseagainstastabilizedhiv1cladecenvelopetrimerbysilicananoparticledelivery
AT monaomohsen augmentingtheimmuneresponseagainstastabilizedhiv1cladecenvelopetrimerbysilicananoparticledelivery
AT christophvoigt augmentingtheimmuneresponseagainstastabilizedhiv1cladecenvelopetrimerbysilicananoparticledelivery
AT nicoleseifert augmentingtheimmuneresponseagainstastabilizedhiv1cladecenvelopetrimerbysilicananoparticledelivery
AT patrickneckermann augmentingtheimmuneresponseagainstastabilizedhiv1cladecenvelopetrimerbysilicananoparticledelivery
AT alexandrahauser augmentingtheimmuneresponseagainstastabilizedhiv1cladecenvelopetrimerbysilicananoparticledelivery
AT songding augmentingtheimmuneresponseagainstastabilizedhiv1cladecenvelopetrimerbysilicananoparticledelivery
AT quentinsattentau augmentingtheimmuneresponseagainstastabilizedhiv1cladecenvelopetrimerbysilicananoparticledelivery
AT martinfbachmann augmentingtheimmuneresponseagainstastabilizedhiv1cladecenvelopetrimerbysilicananoparticledelivery
AT miriambreunig augmentingtheimmuneresponseagainstastabilizedhiv1cladecenvelopetrimerbysilicananoparticledelivery
AT ralfwagner augmentingtheimmuneresponseagainstastabilizedhiv1cladecenvelopetrimerbysilicananoparticledelivery